These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3121253)

  • 1. Mercaptoethane sulphonate in cystinic calculosis therapy.
    Di Silverio F; Gallucci M; Ricciuti GP; Alpi G; Fini D; Cassanelli A; Molinari C
    Contrib Nephrol; 1987; 58():193-5. PubMed ID: 3121253
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cystinic lithiasis and cystinuria. Clinico-therapeutic considerations on 4 cases].
    Rizzello N; Linari F
    Minerva Urol; 1973; 25(3):111-29. PubMed ID: 4745026
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cystinic lithiasis. Current therapeutic trends. Personal experience].
    Tizzani A; Frea B; Linari F
    Minerva Urol; 1981; 33(4):253-8. PubMed ID: 7335035
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.
    Sangster G; Kaye SB; Calman KC; Dalton JF
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):435-6. PubMed ID: 6423391
    [No Abstract]   [Full Text] [Related]  

  • 5. Does 2-mercaptoethane sulphonate (mesna) prevent cyclophosphamide and azathioprine induced immunosuppression? In vitro studies.
    Al-Safi SA; Maddocks JL
    Br J Clin Pharmacol; 1986 Mar; 21(3):267-70. PubMed ID: 2938613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary cystinuria associated with urolithiasis and it's treatment with d-penicillamine].
    Wenzl H; Mauermayer W
    Munch Med Wochenschr; 1969 May; 111(22):1243-8. PubMed ID: 5819093
    [No Abstract]   [Full Text] [Related]  

  • 7. Homozygous cystinuria--evaluation of 35 patients.
    Evans WP; Resnick MI; Boyce WH
    J Urol; 1982 Apr; 127(4):707-9. PubMed ID: 6279888
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic and therapeutic aspects of cystine lithiasis].
    Burgos FJ; García-Cuerpo E; Lovaco F; Berenguer A
    Arch Esp Urol; 1987; 40(6):403-11. PubMed ID: 3314741
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystine calculi. Diagnosis and management.
    Rutchik SD; Resnick MI
    Urol Clin North Am; 1997 Feb; 24(1):163-71. PubMed ID: 9048859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False positive reaction for urinary ketones with mesna.
    Ben Yehuda A; Heyman A; Steiner-Salz D
    Drug Intell Clin Pharm; 1987 Jun; 21(6):547-8. PubMed ID: 3111808
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cystinuria, types, diagnosis and treatment].
    Bremer HJ
    Monatsschr Kinderheilkd (1902); 1969 Jan; 117(1):1-6. PubMed ID: 5398910
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cases of cystinuria with urinary tract stones in sisters].
    Harada T; Takahashi Y; Kato T
    Hinyokika Kiyo; 1971 Sep; 17(9):577-84. PubMed ID: 5166128
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
    Schmähl D; Habs M; Tacchi AM
    Urologe A; 1984 Sep; 23(5):291-6. PubMed ID: 6438859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal encephalopathy with ifosfamide/mesna.
    Verdeguer A; Castel V; Esquembre C; Ferris J; Fernandez JM; Ruiz JG
    Pediatr Hematol Oncol; 1989; 6(4):383-5. PubMed ID: 2518327
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aerosol therapy with Mesna in pneumology (Mistabron ucb) (author's translation)].
    Goossens E
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):200-6. PubMed ID: 827936
    [No Abstract]   [Full Text] [Related]  

  • 16. Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats.
    Kempf SR; Ivankovic S; Wiessler M; Schmähl D
    Br J Cancer; 1985 Dec; 52(6):937-9. PubMed ID: 3935152
    [No Abstract]   [Full Text] [Related]  

  • 17. Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results.
    Kempf SR; Ivankovic S
    Cancer Treat Rev; 1987 Dec; 14(3-4):365-72. PubMed ID: 3125972
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
    Ehrlich RM; Freedman A; Goldsobel AB; Stiehm ER
    J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urolithiasis in children and cystinuria as its cause].
    Dobrynina EIa
    Med Sestra; 1985 Apr; 44(4):38-41. PubMed ID: 3847742
    [No Abstract]   [Full Text] [Related]  

  • 20. Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.
    Ajani JA; Abbruzzese JL; Goudeau P; Faintuch JS; Yeomans AC; Boman BM; Nicaise C; Levin B
    J Clin Oncol; 1988 Nov; 6(11):1703-7. PubMed ID: 3141592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.